Radius Health (RDUS) Misses Q2 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update
August 7, 2018 7:45 AM EDTSecond quarter 2018 TYMLOS sales increase to $22.6 million, a 56% increase over the first quarter of 2018
TYMLOS share in the U.S. anabolic osteoporosis market increased to an average of 19% in the second quarter from 13% in the prior quarter
Radius maintains its 19-21% average 2018 U.S. anabolic osteoporosis market share guidance for TYMLOS and increases its expectations for the U.S. anabolic market to grow by 7-9% in volume versus 2017
Conference call scheduled for 8:00 a.m. ET today
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) --... More
